Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/87659
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPorta-Etessam, J-
dc.contributor.authorGonzález-García, N-
dc.contributor.authorGuerrero, Á L-
dc.contributor.authorGarcía-Azorín, D-
dc.date.accessioned2023-04-17T08:00:43Z-
dc.date.available2023-04-17T08:00:43Z-
dc.date.issued2021-07-08-
dc.identifier.citationNeurologia (Engl Ed).2021;(36)8:638-640-
dc.identifier.urihttps://hdl.handle.net/20.500.12530/87659-
dc.language.isoen-
dc.rightsOpenAccess-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/es/-
dc.subject.meshAntibodies, Monoclonal-
dc.subject.meshCalcitonin Gene-Related Peptide-
dc.subject.meshCalcitonin Gene-Related Peptide Receptor Antagonists-
dc.subject.meshPharmaceutical Preparations-
dc.subject.meshReceptors, Calcitonin Gene-Related Peptide-
dc.titleFailure of monoclonal antibodies against CGRP or its receptor does not imply lack of efficacy of other drugs from the same class.-
dc.typeArtículo-
dc.identifier.pubmedID34246579-
dc.format.volume36-
dc.format.page638-640-
dc.identifier.e-issn2173-5808-
dc.identifier.journalNeurologia (Barcelona, Spain)-
dc.identifier.journalabbreviationNeurologia (Engl Ed)-
dc.identifier.doi10.1016/j.nrleng.2020.10.008-
dc.format.number8-
dc.pubmedtypeLetter-
Appears in Collections:Hospitales > H. U. Clínico San Carlos > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:
File SizeFormat 
Failure of monoclonal antibodies against CGRP.pdf606.44 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons